Decipher Labs Current Share Price | Decipher Labs Stock Screener
DECIPHER
Pharmaceuticals
Decipher Labs Current Stock Price Today
Live Share Price BSE
₹5.50
▼
-0.01 (-0.18%)
As of September 18, 2026, the live Decipher Labs share price (BSE: DECIPHER) is ₹5.50, down 0.18% from the previous close, with shares trading between ₹5.45 and ₹5.51 in today's trading session, and a 52-week range of ₹5.00–₹10.86.
Browse DECIPHER cash flow statement to support your investment research.
Use the Decipher Labs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Decipher Labs Market Cap
₹6.08 Cr.
DECIPHER P/E Ratio (TTM)
-1.88
Decipher Labs P/B Ratio
0.28
EPS (TTM)
₹-3.05
Dividend Yield
-
Debt to Equity
0.01
DECIPHER 52 Week High
₹10.86
Decipher Labs 52 Week Low
₹5.00
Operating Margin
6.00%
Profit Margin
-
DECIPHER Revenue (TTM)
₹4.00
EBITDA
-
Net Income
-
Total Assets
₹26.00
Total Equity
₹23.00
Decipher Labs Current Share Price Chart
Track the current Decipher Labs share price and stock price with an interactive chart. Analyse DECIPHER price trends, trading volume, historical performance, and volatility across different timeframes — the complete Decipher Labs stock quote in one place.
Decipher Labs Company Profile - Fundamental Screener
Screen Decipher Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for DECIPHER shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE643N01012
Decipher Labs Balance Sheet Screener
Screen DECIPHER balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 26 | 34 | 28 | 42 | 39 | 35 | 6 | 3 |
| Current Assets | 21 | 25 | 20 | 38 | 23 | 23 | 6 | 3 |
| Fixed Assets | 3 | 3 | 3 | 3 | 4 | 5 | 0 | 0 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 7 | 8 | 2 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 23 | 22 | 23 | 24 | 14 | 13 | 3 | 2 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 8 | 8 |
| Reserves & Surplus | 13 | 12 | 13 | 14 | 4 | 3 | -6 | -6 |
Decipher Labs Income Statement Screener - Profit & Revenue Analysis
Screen Decipher Labs income statement and profit fundamentals.
Analyze DECIPHER quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Decipher Labs share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4 | 3 | 4 | 3 | 4 | 3 | 11 | 8 | 6 | 6 | 10 | 10 | 8 | 8 | 24 |
| Expenses | 3 | 5 | 10 | 6 | 4 | 4 | 9 | 6 | 7 | 6 | 14 | 10 | 10 | 8 | 21 |
| EBITDA | 0 | -2 | -6 | -3 | 0 | 0 | 2 | 2 | -1 | -1 | -4 | 0 | -2 | 0 | 3 |
| Operating Profit % | 6.00% | -90.00% | -188.00% | -114.00% | 3.00% | -13.00% | 11.00% | 18.00% | -23.00% | -11.00% | -39.00% | -1.00% | -29.00% | 2.00% | 11.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -2 | -6 | -3 | 0 | -1 | 1 | 1 | -1 | -1 | -4 | 0 | -2 | 0 | 3 |
| Tax | 1 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| Net Profit | 0 | -2 | -4 | -3 | 0 | -1 | 1 | 1 | -1 | -1 | -4 | -1 | -2 | 0 | 2 |
| EPS | -0.35 | -2.16 | -4.07 | -3.39 | 0.02 | -0.53 | 1.19 | 0.94 | -1.31 | -0.59 | -4.23 | -0.94 | -1.92 | 0.01 | 1.93 |
Decipher Labs Cash Flow Screener - Liquidity Fundamentals
Screen DECIPHER cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | -10 | 5 | -2 | 8 | 2 | -15 | 0 | 0 |
| Investing Activities | 3 | -2 | -4 | -1 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | -1 | -2 | 1 | 4 | 16 | 0 | 0 |
| Net Cash Flow | -7 | 2 | -8 | 8 | 6 | 1 | 0 | 0 |
Decipher Labs Shareholding Pattern Screener
See Decipher Labs shareholding pattern with promoter, FII, and DII holdings.
Check Decipher Labs promoter holding and ownership changes for DECIPHER on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 16.43% | 16.43% | 16.43% | 16.43% | 16.43% | 16.43% | 16.43% | 16.43% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 78.53% | 78.52% | 80.75% | 78.76% | 78.73% | 78.48% | 80.43% | 80.52% |
| Other Holding | 5.03% | 5.05% | 2.82% | 4.81% | 4.84% | 5.09% | 3.14% | 3.05% |
| Shareholder Count | 29,596 | 29,368 | 31,182 | 30,512 | 30,174 | 29,825 | 33,371 | 32,833 |
Decipher Labs Share Dividend Screener - Share Yield Analysis
Check Decipher Labs dividend history with payout and yield data.
View Decipher Labs dividend details including ex-dates and amounts for DECIPHER stock.
Decipher Labs Stock Index Membership
See which indices include Decipher Labs stock.
Check DECIPHER index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Decipher Labs Market Events Screener - Corporate Actions
Get Decipher Labs corporate actions including splits, bonuses, and buybacks.
Check Decipher Labs stock events that may affect DECIPHER share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | -3.55% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 4.92% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 7.55% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 5.29% |
| 2026-02-12 | 2026-02-12 | Extraordinary General Meeting | NA | -4.56% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -5.53% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | 1.45% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -0.73% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -1.91% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -2.95% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -3.57% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -7.24% |
| 2020-02-12 | 2020-02-12 | Change Of Name | NA | 0.00% |
Decipher Labs Competitors Screener - Peer Comparison
Screen DECIPHER competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Decipher Labs Company Announcements - News Screener
Screen DECIPHER latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-15 | Newspaper Advertisement For AGM Notice For The Financial Year 2025-26. | - |
| 2026-09-14 | Intimation Of Book Closure And Cut Off Date For Annual General Meeting | - |
| 2026-09-14 | Reg. 34 (1) Annual Report. | - |
| 2026-09-14 | Notice Of 40Th Annual General Meeting For The Financial Year 2025-26 Under Regulation 34 Of SEBI (LODR) Regulation 2015. | - |
| 2026-09-11 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-09-11 | Board Meeting Outcome for Outcome Of Board Meeting Held On 05.09.2026. | - |
| 2026-08-14 | Announcements Under Regulation 30 Of SEBI (LODR) Regulations 2015. | - |
| 2026-08-13 | Revised Un-Audited Financial Results For The Quarter Ended 30.06.2026. | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-08-13 | Financial Results For The Quarter Ended 30.06.2026. | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-08-06 | Board Meeting Intimation for Meeting Scheduled To Be Held On 13Th August 2026. | - |
| 2026-07-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-24 | Closure of Trading Window | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-30 | Audited Standalone And Consolidated Financial Results & Statements For The Quarter And Year Ended 31.03.2026 | - |
| 2026-05-30 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 30.05.2026 | - |
| 2026-05-26 | Board Meeting Intimation for 1. Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31 2026. 2. Audit Report (Standalone And Consolidated) For The Year Ended March 31 2026. 3. Any Other Business With The Permiss | - |
| 2026-04-22 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |
| 2026-04-21 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |